tirzepatide europe approval Lilly Receives European Marketing Authorization for in KwikPen® Presentation for Two Indications Zepbound (tirzepatide) superior to Wegovy

ED50 levels for GH release in animal and in vitro studies are much lower than for non-selective secretagogues

4 Current therapeutic landscape and unmet need While resmetirom (a THR- agonist) has recently gained FDA approval for the treatment of MASH (in patients with fibrosis F2-F3), marking the first-ever pharmacological agent for this condition (Liu et al., 2025), there remains no single FDA-approved drug that effectively prevents or reverses the progression of advanced SLD to HCC

Users frequently describe waking up feeling more refreshed despite similar total sleep duration, suggesting improvements in sleep quality beyond simple duration metrics

Animals The GCLM knockout (KO) mouse line (characterized previously 16 ) has been backcrossed into the C57BL/6J background for more than 10 generations